Showing results (331-340 of 341) with videos related to
Sort By:
Pageof 35
British Journal of Cancer|June 1, 1991
Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferonS P Langdon, G J Rabiasz, L Anderson, et al.The Journal of Steroid Biochemistry and Molecular Biology|July 19, 2005
The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancerH Sasano, T J Anderson, S G Silverberg, et al.The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress reportH Sasano, D P Edwards, T J Anderson, et al.British Journal of Cancer|November 1, 1996
Prospective evaluation of prognostic factors in operable breast cancerR A Hawkins, A L Tesdale, M E Killen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trialM J Ellis, A Coop, B Singh, et al.British Journal of Cancer|March 31, 1999
Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868B J Simpson, J M Bartlett, K G Macleod, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 19, 2001
Pharmacokinetics and metabolism of formestane in breast cancer patientsP E Lønning, J Geisler, D C Johannessen, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 30, 1998
Estrogen regulation of transforming growth factor-alpha in ovarian cancerB J Simpson, S P Langdon, G J Rabiasz, et al.British Journal of Cancer|June 27, 2002
Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic indexR A Hawkins, A L Tesdale, R J Prescott, et al.British Journal of Cancer|February 1, 1996
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancerJ M Bartlett, S P Langdon, B J Simpson, et al.Pageof 35